{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:45:57Z","timestamp":1789994757717,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft SFB 894"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.toxlet.2018.11.007","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T02:33:09Z","timestamp":1542594789000},"page":"79-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay"],"prefix":"10.1016","volume":"301","author":[{"given":"Lilian H.J.","family":"Richter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Flockerzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4579-4660","authenticated-orcid":false,"given":"Hans H.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus R.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.toxlet.2018.11.007_bib0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s13181-016-0571-7","article-title":"Acute toxicity associated with use of 5F-derivations of synthetic cannabinoid receptor agonists with analytical confirmation","volume":"12","author":"Abouchedid","year":"2016","journal-title":"J. Med. Toxicol."},{"issue":"1","key":"10.1016\/j.toxlet.2018.11.007_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/dta.1924","article-title":"The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland","volume":"8","author":"Adamowicz","year":"2016","journal-title":"Drug Test. Anal."},{"issue":"9","key":"10.1016\/j.toxlet.2018.11.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108025","article-title":"High content analysis provides mechanistic insights on the pathways of toxicity induced by amine-modified polystyrene nanoparticles","volume":"9","author":"Anguissola","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.toxlet.2018.11.007_bib0020","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00204-015-1513-x","article-title":"The hallucinogenic world of tryptamines: an updated review","volume":"89","author":"Araujo","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.toxlet.2018.11.007_bib0025","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00204-014-1278-7","article-title":"Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of\u2019 legal high\u2019 packages containing synthetic cathinones","volume":"89","author":"Araujo","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"Suppl. 1","key":"10.1016\/j.toxlet.2018.11.007_bib0030","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1016\/S1344-6223(02)00096-2","article-title":"A fatal paramethoxymethamphetamine intoxication","volume":"5","author":"Becker","year":"2003","journal-title":"Leg. Med. (Tokyo)"},{"issue":"8","key":"10.1016\/j.toxlet.2018.11.007_bib0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/jat\/bku048","article-title":"Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22","volume":"38","author":"Behonick","year":"2014","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.toxlet.2018.11.007_bib0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hup.2298","article-title":"MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine;\u2019 sparkle\u2019;\u2019 mindy\u2019) toxicity: a brief overview and update","volume":"28","author":"Corkery","year":"2013","journal-title":"Hum. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.toxlet.2018.11.007_bib0045","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.tiv.2015.04.001","article-title":"Hepatotoxicity of piperazine designer drugs: comparison of different in vitro models","volume":"29","author":"Dias-da-Silva","year":"2015","journal-title":"Toxicol. In Vitro"},{"issue":"1","key":"10.1016\/j.toxlet.2018.11.007_bib0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11845-010-0636-6","article-title":"Acute liver failure following recreational use of psychotropic \"head shop\" compounds","volume":"180","author":"Frohlich","year":"2011","journal-title":"Ir. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.toxlet.2018.11.007_bib0055","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0379-0738(03)00179-8","article-title":"Tissue concentrations of MDMA and its metabolite MDA in three fatal cases of overdose","volume":"135","author":"Garcia-Repetto","year":"2003","journal-title":"Forensic Sci. Int."},{"issue":"6","key":"10.1016\/j.toxlet.2018.11.007_bib0060","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1124\/dmd.109.031831","article-title":"A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues","volume":"38","author":"Hart","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2018.11.007_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.aca.2015.08.018","article-title":"Orbitrap technology for comprehensive metabolite-based liquid chromatographic-high resolution-tandem mass spectrometric urine drug screening\u2013exemplified for cardiovascular drugs","volume":"891","author":"Helfer","year":"2015","journal-title":"Anal. Chim. Acta"},{"issue":"5","key":"10.1016\/j.toxlet.2018.11.007_bib0070","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/dta.1682","article-title":"Elucidation of the metabolites of the novel psychoactive substance 4-methyl-N-ethyl-cathinone (4-MEC) in human urine and pooled liver microsomes by GC-MS and LC-HR-MS\/MS techniques and of its detectability by GC\u2013MS or LC\u2013MS(n) standard screening approaches","volume":"7","author":"Helfer","year":"2015","journal-title":"Drug Test. Anal."},{"issue":"1","key":"10.1016\/j.toxlet.2018.11.007_bib0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/dmd.107.017418","article-title":"HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.toxlet.2018.11.007_bib0080","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/1556-4029.12202","article-title":"Methylenedioxypyrovalerone (\"bath salts\"), related death: case report and review of the literature","volume":"58","author":"Kesha","year":"2013","journal-title":"J. Forensic Sci."},{"issue":"1","key":"10.1016\/j.toxlet.2018.11.007_bib0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13643-016-0375-5","article-title":"The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol","volume":"5","author":"Khaled","year":"2016","journal-title":"Syst. Rev."},{"issue":"2","key":"10.1016\/j.toxlet.2018.11.007_bib0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00007691-200204000-00009","article-title":"Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives","volume":"24","author":"Kraemer","year":"2002","journal-title":"Ther. Drug Monit."},{"issue":"6","key":"10.1016\/j.toxlet.2018.11.007_bib0095","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ceca.2015.10.003","article-title":"A comparison of fluorescent Ca(2)(+) indicators for imaging local Ca(2)(+) signals in cultured cells","volume":"58","author":"Lock","year":"2015","journal-title":"Cell Calcium"},{"key":"10.1016\/j.toxlet.2018.11.007_bib0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tox.2017.06.004","article-title":"Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones","volume":"387","author":"Luethi","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2018.11.007_bib0105","series-title":"Maurer\/Meyer\/Helfer\/Weber MMHW LC-HR-MS\/MS Library of Drugs, Poisons, and Their Metabolites","author":"Maurer","year":"2017"},{"issue":"5","key":"10.1016\/j.toxlet.2018.11.007_bib0110","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2174\/138920010791526042","article-title":"Metabolism of designer drugs of abuse: an updated review","volume":"11","author":"Meyer","year":"2010","journal-title":"Curr. Drug Metab."},{"issue":"12","key":"10.1016\/j.toxlet.2018.11.007_bib0115","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/jms.1859","article-title":"Studies on the metabolism of the alpha-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC\u2013MS and LC-high-resolution MS and its detectability in urine by GC\u2013MS","volume":"45","author":"Meyer","year":"2010","journal-title":"J. Mass Spectrom."},{"issue":"3","key":"10.1016\/j.toxlet.2018.11.007_bib0120","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00216-010-3636-5","article-title":"Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry","volume":"397","author":"Meyer","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.toxlet.2018.11.007_bib0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.aca.2014.03.017","article-title":"Methylenedioxy designer drugs: mass spectrometric characterization of their glutathione conjugates by means of liquid chromatography-high-resolution mass spectrometry\/mass spectrometry and studies on their glutathionyl transferase inhibition potency","volume":"822","author":"Meyer","year":"2014","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.toxlet.2018.11.007_bib0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1081\/DMR-100100562","article-title":"Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine","volume":"32","author":"Musshoff","year":"2000","journal-title":"Drug Metab. Rev."},{"issue":"3","key":"10.1016\/j.toxlet.2018.11.007_bib0135","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1021\/acs.chemrestox.6b00403","article-title":"Validation of a multiparametric, high-content-screening assay for predictive\/investigative cytotoxicity: evidence from technology transfer studies and literature review","volume":"30","author":"O\u2019Brien","year":"2017","journal-title":"Chem. Res. Toxicol."},{"issue":"9","key":"10.1016\/j.toxlet.2018.11.007_bib0140","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00204-006-0091-3","article-title":"High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening","volume":"80","author":"O\u2019Brien","year":"2006","journal-title":"Arch. Toxicol."},{"issue":"3","key":"10.1016\/j.toxlet.2018.11.007_bib0145","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.vascn.2013.08.001","article-title":"A high content screening assay to predict human drug-induced liver injury during drug discovery","volume":"68","author":"Persson","year":"2013","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"23","key":"10.1016\/j.toxlet.2018.11.007_bib0150","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1007\/s00216-016-9740-4","article-title":"Metabolic fate of desomorphine elucidated using rat urine, pooled human liver preparations, and human hepatocyte cultures as well as its detectability using standard urine screening approaches","volume":"408","author":"Richter","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.toxlet.2018.11.007_bib0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jpba.2017.05.028","article-title":"Pooled human liver preparations, HepaRG, or HepG2 cell lines for metabolism studies of new psychoactive substances? A study using MDMA, MDBD, butylone, MDPPP, MDPV, MDPB, 5-MAPB, and 5-API as examples","volume":"143","author":"Richter","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.toxlet.2018.11.007_bib0160","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.toxlet.2017.07.901","article-title":"New psychoactive substances: studies on the metabolism of XLR-11, AB-PINACA, FUB-PB-22, 4-methoxy-alpha-PVP, 25-I-NBOMe, and meclonazepam using human liver preparations in comparison to primary human hepatocytes, and human urine","volume":"280","author":"Richter","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2018.11.007_bib0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neulet.2016.06.029","article-title":"Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells","volume":"629","author":"Rosas-Hernandez","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.toxlet.2018.11.007_bib0170","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1389200054021825","article-title":"Metabolism of designer drugs of abuse","volume":"6","author":"Staack","year":"2005","journal-title":"Curr. Drug Metab."},{"issue":"7","key":"10.1016\/j.toxlet.2018.11.007_bib0175","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00204-015-1503-z","article-title":"High-content screening technology for studying drug-induced hepatotoxicity in cell models","volume":"89","author":"Tolosa","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2018.11.007_bib0180","series-title":"World Drug Report. United Nations Publication Sales No. E.16.XI.7","author":"UNODC","year":"2016"},{"issue":"1","key":"10.1016\/j.toxlet.2018.11.007_bib0185","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/kfw105","article-title":"Editor\u2019s highlight: characterization of hepatotoxicity mechanisms triggered by designer cathinone drugs (beta-Keto amphetamines)","volume":"153","author":"Valente","year":"2016","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.toxlet.2018.11.007_bib0190","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00204-015-1653-z","article-title":"3,4-Methylenedioxypyrovalerone (MDPV): in vitro mechanisms of hepatotoxicity under normothermic and hyperthermic conditions","volume":"90","author":"Valente","year":"2016","journal-title":"Arch. Toxicol."},{"issue":"6","key":"10.1016\/j.toxlet.2018.11.007_bib0195","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00216-014-7668-0","article-title":"Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry","volume":"406","author":"Wohlfarth","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"issue":"5","key":"10.1016\/j.toxlet.2018.11.007_bib0200","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1248\/bpb.b17-00913","article-title":"Comparison of drug metabolism and its related hepatotoxic effects in HepaRG, cryopreserved human hepatocytes, and HepG2 cell cultures","volume":"41","author":"Yokoyama","year":"2018","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.toxlet.2018.11.007_bib0205","first-page":"1","article-title":"Study on the metabolism of 5,6-methylenedioxy-2-aminoindane (MDAI) in rats: identification of urinary metabolites","author":"Zidkova","year":"2016","journal-title":"Xenobiotica"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418317958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427418317958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T11:49:01Z","timestamp":1544615341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427418317958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":41,"alternative-id":["S0378427418317958"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.11.007","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxicity of new psychoactive substances and other drugs of abuse studied in human HepG2 cells using an adopted high content screening assay","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}